StockData
Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc. (RXRX) stock

RXRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/302% below fair value
$2.90−0.28 (-8.79%)

Close on Nov 16, 2026Market cap $1.56BP/E –Yield –

Recursion Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Recursion Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -991.7%. For fiscal 2025 it was -867.9%, against -814.1% the year before. The highest annual figure on record is -616.7% in fiscal 2022.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-867.9%−53.8
FY2024Dec 31, 2024-814.1%−28.8
FY2023Dec 31, 2023-785.3%−168.6
FY2022Dec 31, 2022-616.7%+1179.0
FY2021Dec 31, 2021-1795.8%+339.9
FY2020Dec 31, 2020-2135.7%+556.9
FY2019Dec 31, 2019-2692.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1759.7%−842.9
Q1 FY2026Mar 31, 2026-1985.6%−687.7
Q4 FY2025Dec 31, 2025-304.8%+3737.6
Q3 FY2025Sep 30, 2025-3327.6%−2950.5
Q2 FY2025Jun 30, 2025-916.8%−219.4
Q1 FY2025Mar 31, 2025-1297.9%−599.4
Q4 FY2024Dec 31, 2024-4042.4%−3134.0
Q3 FY2024Sep 30, 2024-377.1%+568.0
Q2 FY2024Jun 30, 2024-697.4%+44.3
Q1 FY2024Mar 31, 2024-698.4%−122.6
Q4 FY2023Dec 31, 2023-908.4%−462.5
Q3 FY2023Sep 30, 2023-945.1%−469.6
Q2 FY2023Jun 30, 2023-741.7%+120.8
Q1 FY2023Mar 31, 2023-575.8%+473.9
Q4 FY2022Dec 31, 2022-445.9%+2118.6
Q3 FY2022Sep 30, 2022-475.5%+1355.7
Q2 FY2022Jun 30, 2022-862.5%+743.2
Q1 FY2022Mar 31, 2022-1049.7%+140.1
Q4 FY2021Dec 31, 2021-2564.5%−1613.9
Q3 FY2021Sep 30, 2021-1831.2%+361.4
Q2 FY2021Jun 30, 2021-1605.7%+8188.4
Q1 FY2021Mar 31, 2021-1189.9%+29381.8
Q4 FY2020Dec 31, 2020-950.6%–
Q3 FY2020Sep 30, 2020-2192.6%–
Q2 FY2020Jun 30, 2020-9794.1%–
Q1 FY2020Mar 31, 2020-30571.7%–

More Recursion Pharmaceuticals figures

See a number that looks wrong?